Five Prime Therapeutics, Inc. News Headlines

Get FPRX Alerts
*Delayed - data as of Oct. 22, 2014  -  Find a broker to begin trading FPRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Filtered By
Ordered By
Five Prime Therapeutics (FPRX) Initiated As a Sell
10/22/2014 9:13:00 AM - TheStreet

Five Prime Therapeutics' Novel Target Licensed by Glaxo - Analyst Blog
9/17/2014 6:00:00 PM - Zacks.com

Five Prime: Glaxo Exercises Option for Rights to Muscle-Disease Products
9/16/2014 10:10:00 AM - Dow Jones Business News

Five Prime: Option Exercise By Glaxo For License To Muscle Disease Target
9/15/2014 4:23:00 PM - RTT News

Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies
8/12/2014 10:43:00 AM - Seeking Alpha

Five Prime Therapeutics (FPRX) Jumps: Stock Adds 10.3% in Session - Tale of the Tape
8/12/2014 8:51:00 AM - Zacks.com

Bristol-Myers & CytomX Therapeutics Join Forces - Analyst Blog
5/28/2014 11:50:00 AM - Zacks.com

Bristol-Myers, Samsung BioLogics Extend Ties - Analyst Blog
4/23/2014 5:30:01 PM - Zacks.com

Should Five Prime Therapeutics (FPRX) Be On Your Radar Now? - Tale of the Tape
4/10/2014 8:53:01 AM - Zacks.com

Earnings Estimates Moving Higher for Five Prime (FPRX): Time to Buy? - Tale of the Tape
4/4/2014 8:47:01 AM - Zacks.com

Bristol Myers Deal Overshadows Q4 loss at Five Prime - Analyst Blog
3/27/2014 11:00:01 AM - Zacks.com

Bristol-Myers, Five Prime Join Forces, Shares up - Analyst Blog
3/18/2014 12:00:01 PM - Zacks.com

Five Prime Therapeutics (FPRX) Surges: Stock Moves 22.6% Higher - Tale of the Tape
3/18/2014 9:18:01 AM - Zacks.com

Five Prime: A Growing Oncology And Inflammatory Player With A Promising Pipeline
10/30/2013 2:47:00 PM - Seeking Alpha

Five Prime Therapeutics - Another Risky Cancer Research Public Offering
9/23/2013 7:05:00 AM - Seeking Alpha

Five Prime Therapeutics prices IPO at $13, within the range
9/17/2013 8:08:06 PM - Renaissance Capital

IPO Preview: Five Prime Therapeutics
9/17/2013 4:34:00 PM - Seeking Alpha

12 U.S. IPOs Planned For The Week Of September 16
9/16/2013 3:57:00 PM - Seeking Alpha

U.S. IPO Recap: Benefitfocus, Six Others Set Terms As Calendar Rebuilds
9/10/2013 8:21:00 AM - Seeking Alpha

US IPO Recap: Benefitfocus, six others set terms as calendar rebuilds
9/8/2013 10:23:54 PM - Renaissance Capital

Biotech Five Prime Therapeutics sets terms for $52 million IPO
9/4/2013 5:43:04 PM - Renaissance Capital

U.S. IPO Recap: 11 Deals Prince In Busiest Week Since November 2007, 8 Companies Set Terms
7/30/2013 7:27:00 AM - Seeking Alpha

Biotech Five Prime Therapeutics files for a $60 million IPO
7/28/2013 3:55:32 PM - Renaissance Capital